Cochrane · systematic review · CD005154
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia
Alabed, S, Sabouni, A, Providencia, R, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
2
No studies
2
Included studies
NR
No studies 2 · 50%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 1 · 25%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Adenosine compared with calcium channel antagonists for supraventricular tachycardia
Population: patients with supraventricular tachycardia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Odds of reversion Adenosine vs calcium channel antagonists | no estimate extracted | 622 participants | Moderate Downgraded: imprecision |
Major adverse event: hypotension Adenosine vs calcium channel antagonists | no estimate extracted | 306 participants | Low Downgraded: imprecision |
Length of stay in hospital Adenosine vs calcium channel antagonists | no estimate extracted | NR | No studies |
Patient satisfaction Adenosine vs calcium channel antagonists | no estimate extracted | NR | No studies |